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Ectopic G-protein expression in dopamine and serotonin neurons
blocks cocaine sensitization in Drosophila melanogaster
H. Li*, S. Chaney*, M. Forte† and J. Hirsh*
Sensitization to repeated doses of psychostimulants is
thought to be an important component underlying the
addictive process in humans [1–4]. In all vertebrate
animal models, including humans [5], and even in fruit
flies, sensitization is observed after repeated exposure
to volatilized crack cocaine [6]. In vertebrates,
sensitization is thought to be initiated by processes
occurring in brain regions that contain dopamine cell
bodies [2,7]. Here, we show that modulated cell
signaling in the Drosophila dopamine and serotonin
neurons plays an essential role in cocaine sensitization.
Targeted expression of either a stimulatory (Gαs) or
inhibitory (Gαi) Gα subunit, or tetanus toxin light chain
(TNT) in dopamine and serotonin neurons of living flies
blocked behavioral sensitization to repeated cocaine
exposures. These flies showed alterations in their initial
cocaine responsiveness that correlated with
compensatory adaptations of postsynaptic receptor
sensitivity. Finally, repeated drug stimulation of a nerve
cord preparation that is postsynaptic to the brain amine
cells failed to induce sensitization, further showing the
importance of presynaptic modulation in sensitization. 
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Results and discussion
Altered cocaine responsiveness in lines expressing Gαs,
Gαi or TNT in dopamine and serotonin neurons
To make a binary system for the targeted expression of
gene products in dopamine and serotonin neurons, we
generated pDdc–GAL4 transgenic flies expressing the
yeast GAL4 transcriptional activator under the control of
the Ddc (dopa decarboxylase) promoter (see Materials
and methods). Transgenic flies expressing either Gαi or
Gαs were generated by crossing flies containing
Ddc–GAL4 with flies expressing either Gαi or Gαs under
the control of the UAS, GAL4-responsive site. In verte-
brate aminergic neurons, amine synthesis and release are
negatively regulated by Gαi-coupled autoreceptors [8,9].
If a parallel situation exists in the Drosophila central
nervous system (CNS), misexpression of Gαi should
decrease amine synthesis and release, whereas targeted
misexpression of Gαs might compete with the endoge-
nously expressed Gαi, resulting in increased amine syn-
thesis and release. As we cannot measure amine release
directly in this system, we expressed TNT in these
neurons as a control, because expression of TNT in
Drosophila abolishes evoked synaptic release and par-
tially inhibits spontaneous release [10].
Administration of cocaine to transgenic lines expressing
either Gαi or TNT in the dopamine and serotonin
neurons resulted in a similar phenotype of hypersensitiv-
ity to the initial exposure to cocaine, where hypersensi-
tivity is indicated by an increased fraction of flies
showing severe responses to the challenge dose of
cocaine (Figure 1a,b). In contrast, fly lines expressing
Gαs in these neurons showed the opposite phenotype,
that is, reduced responsiveness to cocaine compared
with controls (Figure 1c). These results are most simply
interpreted as being due to compensatory postsynaptic
responses to altered levels of amine release, analogous to
the postsynaptic hypersensitivity observed in verte-
brates with induced deficits in dopamine release [11,12].
As a control for the effects of the pDdc–GAL4 driver, we
crossed the pDdc–GAL4 transgenic flies with a line
expressing a mutant form of TNT [10]. These flies
showed normal responsiveness to a single dose of
cocaine, and normal sensitization to repeated doses (data
not shown). 
Altered postsynaptic functions in flies expressing Gαs,
Gαi or TNT
To determine whether the observed changes in cocaine
responsiveness in the fly lines expressing Gαs, Gαi or
TNT were due to altered postsynaptic function, we exam-
ined the sensitivity of receptors activated by the
dopamine D2-like agonist quinpirole in the Drosophila
nerve cord, which contains neurons that are postsynaptic
to the brain aminergic neurons. Quinpirole stimulates
locomotor responses in decapitated flies [13], the magni-
tude of this effect presumably reflecting the state of the
postsynaptic quinpirole-sensitive receptors before decapi-
tation. Using this behaviorally active preparation, we
found that the responsiveness of the nerve-cord receptors
correlated with the magnitude of cocaine responsiveness
in vivo. Both the Gαi- and TNT-expressing lines showed
significantly increased locomotor responses compared
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with control lines (Figure 2a,b), whereas Gαs-expressing
flies showed decreased locomotor responses (Figure 2c).
We conclude that long-term deviations in the levels of
released amines can be compensated for by reciprocal
changes in postsynaptic receptor sensitivity. Furthermore,
the sensitivity of these postsynaptic receptors correlates
with the magnitude of cocaine responsiveness in vivo. 
The overall locomotor activity in these lines showing
altered cocaine responsiveness appeared normal when
assayed in a Drosophila activity monitor (data not shown).
Thus, the degree of postsynaptic receptor compensation
is sufficient to maintain normal homeostasis in the amin-
ergic control of locomotor activity.
Lack of sensitization in lines expressing Gαs, Gαi or TNT in
dopamine and serotonin neurons
In vertebrates, sensitization appears to result from modu-
lations in aminergic neurons that occur in response to
repeated psychostimulant exposure [3,14,15], although the
precise nature of these altered functions is not clear. To
determine whether expression of Gαs, Gαi or TNT in
aminergic cells interferes with sensitization, flies express-
ing these genes in dopamine and serotonin neurons were
given three doses of cocaine and behavioral responses
were determined after each exposure (Figure 3).
Repeated exposures led to robust sensitization in controls,
but expression of any of these gene products in the
dopamine and serotonin neurons abolished sensitization. 
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Figure 1
Alterations in the initial cocaine
responsiveness of male flies expressing TNT,
Gαi or Gαs in dopamine and serotonin
neurons. TNT, Gαs and Gαi were expressed
under UAS control using either the
pDdc-GAL4.36 or pDdc-GAL4.3D drivers
(see Materials and methods). Flies were
exposed to volatilized free base cocaine and
the responses were scored using a behavioral
scoring system [6]. Behavioral scores range
from 0 (normal) to 7 (death). The fractions of
flies showing severe responses,
corresponding to a behavioral score of ≥ 5
(bouts of rapid twirling and erratic jumping or
paralysis), at any time during a 5 min viewing
period after cocaine exposure are plotted. In
each panel, different amounts of cocaine
were used to compensate for the altered
initial responsiveness. (a) TNT-expressing
flies and controls were exposed to 60 µg
cocaine. (b) Gαi-expressing flies and controls
were exposed to 75 µg cocaine.
(c) Gαs-expressing flies and controls were
exposed to 90 µg cocaine. In all panels, the
responses of a wild-type (w1118) line and of
UAS flies in the absence of a GAL4 driver are
shown as controls. For each strain, 55–120
flies were tested. Asterisks indicate significant
differences (Chi squared) in responsiveness
compared with the wild-type controls
(p < 0.05). Additional controls (data not
shown) indicate that the nature of the
cocaine-induced behaviors is the same in the
wild-type and UAS-expressing lines, and that
similar results are observed if different
behavioral criteria and different cocaine
amounts are used.
Figure 2
Alterations in the responsiveness of
postsynaptic nerve-cord dopamine receptors
in flies expressing TNT, Gαi or Gαs in
dopamine and serotonin neurons. Locomotor
responses stimulated by the D2-like agonist
quinpirole were measured as the amount of
induced locomotion in a 2 min viewing
period after drug administration. In
(a,b), 2 mM quinpirole was used, whereas in
(c), 5 mM quinpirole was used to
compensate for the decreased
responsiveness of the Gαs-expressing flies.
(a) TNT-expressing flies and controls
(n = 45–60 for each line). (b) Gαi-expressing
flies and controls (n = 55–60 for each
control line and 20–35 for each
Gαi-expressing line). (c) Gαs-expressing flies
and controls (n = 50–85 for each line). In all
panels, the responses of a wild-type (w1118)
line and of UAS flies in the absence of a
GAL4 driver are shown as controls.
Asterisks indicate significant differences
(ANOVA) in induced locomotion compared
with the wild-type controls (p < 0.001).
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Because ectopic G-protein expression in these presynaptic
neurons blocked sensitization, we infer that sensitization
requires modulation of G-protein signaling following even a
single cocaine exposure, or that the ectopic G-protein
expression is sufficient to block other modulations in cell
signaling. TNT blocks evoked synaptic release, such that it
will block any effects of G-protein modulation of amine
release in these neurons. Presumably, there is a small
amount of residual non-evoked release in these flies that is
sufficient to allow survival, as has been seen previously for
glutamate release at the neuromuscular junction after inhi-
bition with tetanus toxin [10].
Misexpression of Gαs, Gαi or TNT during development
produced neither lethality nor overt behavioral pheno-
types, which suggests that perturbations of neurotransmis-
sion either through disrupted G-protein signaling or TNT
expression do not significantly affect basic neuronal func-
tion. Furthermore, confocal images of CNS immunos-
tained for Ddc or serotonin showed grossly normal
morphology when Gαs, Gαi or TNT were expressed in the
dopamine and serotonin neurons (data not shown), sug-
gesting that the observed cocaine phenotypes do not
result from developmental abnormalities.
Failure of a nerve cord preparation to sensitize
Sensitization in vertebrates can be elicited by direct injec-
tion of psychostimulants into the dopamine-cell-rich ventral
tegmental area [15], but injections into the region to which
the ventral tegmental neurons project, the nucleus accum-
bens, fail to result in sensitization (reviewed in [14]). Sensi-
tization results in long-lasting hypersensitivity of the
postsynaptic receptors, both in vertebrates [2,16] and in
Drosophila. When living flies are sensitized by repeated
exposures to cocaine and subsequently decapitated, the
decapitated preparations show increased responsiveness
when challenged with quinpirole [17]. In contrast, exposing
decapitated preparations of drug-naive flies to cocaine or
quinpirole failed to induce hypersensitive responses to a
subsequent dose of quinpirole (Figure 4). These results
show further parallels with results in vertebrates, in that the
development of sensitization critically requires modulation
in aminergic cells. However, repeated cocaine or dopamine
agonist exposures of this nerve cord preparation, which is
postsynaptic to the brain aminergic neurons, is not sufficient
to yield sensitization. 
Cocaine responsiveness correlates with compensatory
adaptations of postsynaptic responsiveness
The results presented here unambiguously show critical
roles for the biogenic amines dopamine and/or serotonin in
modulating cocaine responsiveness and sensitization. The
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Figure 3
Expression of Gαs, Gαi or TNT in dopamine
and serotonin neurons blocks sensitization to
repeated cocaine exposures. Male flies
expressing these gene products in dopamine
and serotonin neurons were exposed to three
cocaine doses at 0, 6 and 24 h, and the
behavioral responses were determined [6].
The fractions of flies showing severe
responses (behavioral score ≥5) in a 5 min
scoring episode after each exposure are
plotted (n = 55–125 for each line). Asterisks
indicate significant differences in responses to
the first exposure compared with subsequent
exposures (Chi squared; p < 0.01). (a,b) Flies
expressing TNT or Gαi and controls were
exposed to 40 µg cocaine. (c) Gαs-expressing
flies and controls were exposed to 90 µg
cocaine. Cocaine doses were altered to
compensate for the different initial
responsiveness of the flies expressing the
given transgenes. The lack of sensitization in
wild-type flies exposed to 90 µg cocaine is
due to the near-maximal initial responses to
this high dose. Each line expressing an
ectopic gene product was tested at additional
cocaine exposure levels, but sensitization was
never observed (data not shown).
Figure 4
Repeated stimulation of the nerve cord with cocaine or the dopamine
agonist quinpirole fails to induce sensitization. Drugs were applied to the
nerve cords of decapitated male flies (0.05 mg/ml cocaine–HCl, 2 mM
quinpirole, or buffer), which were challenged with 2 mM quinpirole 6 h
later. Locomotion following quinpirole addition was assayed in a 2 min
viewing period. Average locomotion ± SEM is shown (n = 15–21). 
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directionality of the alterations in cocaine responsiveness
observed is somewhat counterintuitive; long-term expres-
sion of gene products that are expected to reduce amine
release increased responsiveness to cocaine, whereas
expression of gene products expected to increase amine
release decreased responsiveness. These results are consis-
tent with the measured changes in the responsiveness of
the nerve cord dopamine receptors, which are in a compen-
satory direction to the expected alterations in the level of
release. These compensatory neuroadaptations have paral-
lels in several situations in vertebrates: animal models that
have been amine-depleted with reserpine show sensitized
responsiveness of postsynaptic amine receptors [18,19], as
do animals with unilateral dopamine cell ablations [12].
Similarly, in the clinical setting, postsynaptic dopamine
receptor modulation is thought to complicate long-term
treatment of Parkinson’s patients with L-DOPA [20,21].
Similar compensatory postsynaptic changes are observed in
mice heterozygous for loss of VMAT2 [11,22], the primary
vesicular monoamine transporter in the brain. In parallel
with our results in Drosophila, these animals show no addi-
tional sensitized response when repeatedly exposed to
amphetamine [11]. This indicates the determining impact
of presynaptic alterations in amine release on postsynaptic
receptor responsiveness.
We note a concurrent report in this issue [23] showing that
treatment of Drosophila with a dopamine synthesis
inhibitor that reduces whole fly dopamine levels ~tenfold
leads to reduced responses to cocaine, the opposite of our
findings. It remains to be elucidated whether this discrep-
ancy results from differences in the time courses of the
pharmacological versus developmental approaches, from
differences in pharmacological specificity, or from differ-
ences in amounts of inhibition of amine release. 
Supplementary material
Additional results and discussion and additional methodological details
are available at http://current-biology.com/supmat/supmatin.htm.
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